Overview

Company Name
Modalis Therapeutics Corporation
Foundation
January 2016
Representative Directors
Haru Morita
Headquarters
3-11-5 Nihonbashi-Honcho, Nihonbashi-Lifescience-Bldg.2 7F Chuo-ku, Tokyo,103-0023 JAPAN
※ On September 1st, 2020, the Japan office of Modalis has relocated.
U.S. Office R&D Operations
Modalis Therapeutics Inc.(51 Moulton Street, Cambridge, MA 02138)
Scope of Business
Drug development
Number of Employees

22 (as of end 2020, consolidated)

MODALIS

Modalis (pronounced “MO-DA-LIS”) is an original name that the Company has chosen to hope Company’s proprietary gene modulation technology, CRISPR-GNDM, to be a new modality (therapeutic technology) to assist patients fighting with genetic disorders. It is the key to treatment of genetic diseases, and the logo of the company name expresses “a gene switch” becoming the target of the CRISPR-GNDM technology.

MODALIS